{"id":1281480,"date":"2024-05-08T10:53:11","date_gmt":"2024-05-08T05:23:11","guid":{"rendered":"https:\/\/trak.in\/stories\/?p=1281480"},"modified":"2024-05-08T10:53:31","modified_gmt":"2024-05-08T05:23:31","slug":"covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects","status":"publish","type":"post","link":"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/","title":{"rendered":"Covishield Vaccine No Longer Being Sold: Company Stops Production, Sales After Admittance Of Side-Effects"},"content":{"rendered":"\n

AstraZeneca, in coordination with Oxford University, has initiated a worldwide withdrawal<\/a> of its COVID-19 vaccine, Covishield, produced by the Serum Institute of India. This decision follows reports of rare side effects associated with the jab, including Thrombosis with Thrombocytopenia Syndrome (TTS), causing blood clots and low platelet counts.<\/p>\n\n\n\n

\"Covishield<\/figure>\n\n\n\n

Commercial Reasons Behind Withdrawal<\/h4>\n\n\n\n

Citing a surplus of updated vaccines targeting new variants of the virus, AstraZeneca stated that the withdrawal was primarily driven by commercial reasons. The company acknowledged that the availability of newer vaccines has rendered Covishield obsolete, prompting its voluntary withdrawal from the market.<\/p>\n\n\n\n

Legal Challenges and Admissions<\/h4>\n\n\n\n

Facing a 100 million pound lawsuit in the UK over alleged adverse effects of the vaccine, AstraZeneca admitted in court documents the potential for Covishield to cause TTS in rare cases. Despite this admission, the pharmaceutical giant maintains that the withdrawal decision is unrelated to the ongoing legal proceedings.<\/p>\n\n\n\n

Recognition of Past Contributions<\/h4>\n\n\n\n

AstraZeneca highlighted its significant contribution to combating the global pandemic, emphasizing that over 6.5 million lives were saved in the first year of vaccine deployment, with three billion doses supplied worldwide. The company’s efforts have garnered recognition from governments worldwide, positioning its vaccine as a critical tool in pandemic mitigation.<\/p>\n\n\n\n

Future Outlook and Vaccine Replacement<\/h4>\n\n\n\n

With the emergence of multiple COVID-19 variants, experts anticipate the withdrawal of “monovalent” vaccines targeting the original strain, including Covishield. Updated vaccines capable of addressing a broader spectrum of variants are expected to replace these older versions, aligning with evolving public health needs.<\/p>\n","protected":false},"excerpt":{"rendered":"

AstraZeneca, in coordination with Oxford University, has initiated a worldwide withdrawal of its COVID-19 vaccine, Covishield, produced by the Serum Institute of India. This decision follows reports of rare side effects associated with the jab, including Thrombosis with Thrombocytopenia Syndrome (TTS), causing blood clots and low platelet counts. Commercial Reasons Behind Withdrawal Citing a surplus […]<\/p>\n","protected":false},"author":30,"featured_media":1281481,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[401],"tags":[5237,5238],"class_list":["post-1281480","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","tag-covishield","tag-vaccine"],"acf":[],"yoast_head":"\nCovishield Vaccine No Longer Being Sold: Company Stops Production, Sales After Admittance Of Side-Effects - Trak.in - Indian Business of Tech, Mobile & Startups<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Covishield Vaccine No Longer Being Sold: Company Stops Production, Sales After Admittance Of Side-Effects - Trak.in - Indian Business of Tech, Mobile & Startups\" \/>\n<meta property=\"og:description\" content=\"AstraZeneca, in coordination with Oxford University, has initiated a worldwide withdrawal of its COVID-19 vaccine, Covishield, produced by the Serum Institute of India. This decision follows reports of rare side effects associated with the jab, including Thrombosis with Thrombocytopenia Syndrome (TTS), causing blood clots and low platelet counts. Commercial Reasons Behind Withdrawal Citing a surplus […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/\" \/>\n<meta property=\"og:site_name\" content=\"Trak.in - Indian Business of Tech, Mobile & Startups\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-08T05:23:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-08T05:23:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-14-1280x720-1-1024x576-1-1024x576-1-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mohul Ghosh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mohul Ghosh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/\",\"url\":\"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/\",\"name\":\"Covishield Vaccine No Longer Being Sold: Company Stops Production, Sales After Admittance Of Side-Effects - Trak.in - Indian Business of Tech, Mobile & Startups\",\"isPartOf\":{\"@id\":\"https:\/\/trak.in\/stories\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-14-1280x720-1-1024x576-1-1024x576-1-1.jpg\",\"datePublished\":\"2024-05-08T05:23:11+00:00\",\"dateModified\":\"2024-05-08T05:23:31+00:00\",\"author\":{\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7\"},\"breadcrumb\":{\"@id\":\"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/#primaryimage\",\"url\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-14-1280x720-1-1024x576-1-1024x576-1-1.jpg\",\"contentUrl\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-14-1280x720-1-1024x576-1-1024x576-1-1.jpg\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/trak.in\/stories\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Covishield Vaccine No Longer Being Sold: Company Stops Production, Sales After Admittance Of Side-Effects\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/trak.in\/stories\/#website\",\"url\":\"https:\/\/trak.in\/stories\/\",\"name\":\"Trak.in - Indian Business of Tech, Mobile & Startups\",\"description\":\"Trak.in is a popular Indian Business, Technology, Mobile & Startup blog featuring trending News, views and analytical take on Technology, Business, Finance, Telecom, Mobile, startups & Social Media Space\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/trak.in\/stories\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7\",\"name\":\"Mohul Ghosh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g\",\"caption\":\"Mohul Ghosh\"},\"url\":\"https:\/\/trak.in\/stories\/author\/mohul-ghosh\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Covishield Vaccine No Longer Being Sold: Company Stops Production, Sales After Admittance Of Side-Effects - Trak.in - Indian Business of Tech, Mobile & Startups","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/","og_locale":"en_US","og_type":"article","og_title":"Covishield Vaccine No Longer Being Sold: Company Stops Production, Sales After Admittance Of Side-Effects - Trak.in - Indian Business of Tech, Mobile & Startups","og_description":"AstraZeneca, in coordination with Oxford University, has initiated a worldwide withdrawal of its COVID-19 vaccine, Covishield, produced by the Serum Institute of India. This decision follows reports of rare side effects associated with the jab, including Thrombosis with Thrombocytopenia Syndrome (TTS), causing blood clots and low platelet counts. Commercial Reasons Behind Withdrawal Citing a surplus […]","og_url":"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/","og_site_name":"Trak.in - Indian Business of Tech, Mobile & Startups","article_published_time":"2024-05-08T05:23:11+00:00","article_modified_time":"2024-05-08T05:23:31+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-14-1280x720-1-1024x576-1-1024x576-1-1.jpg","type":"image\/jpeg"}],"author":"Mohul Ghosh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mohul Ghosh","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/","url":"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/","name":"Covishield Vaccine No Longer Being Sold: Company Stops Production, Sales After Admittance Of Side-Effects - Trak.in - Indian Business of Tech, Mobile & Startups","isPartOf":{"@id":"https:\/\/trak.in\/stories\/#website"},"primaryImageOfPage":{"@id":"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/#primaryimage"},"image":{"@id":"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/#primaryimage"},"thumbnailUrl":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-14-1280x720-1-1024x576-1-1024x576-1-1.jpg","datePublished":"2024-05-08T05:23:11+00:00","dateModified":"2024-05-08T05:23:31+00:00","author":{"@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7"},"breadcrumb":{"@id":"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/#primaryimage","url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-14-1280x720-1-1024x576-1-1024x576-1-1.jpg","contentUrl":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-14-1280x720-1-1024x576-1-1024x576-1-1.jpg","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/trak.in\/stories\/covishield-vaccine-no-longer-being-sold-company-stops-production-sales-after-admittance-of-side-effects\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/trak.in\/stories\/"},{"@type":"ListItem","position":2,"name":"Covishield Vaccine No Longer Being Sold: Company Stops Production, Sales After Admittance Of Side-Effects"}]},{"@type":"WebSite","@id":"https:\/\/trak.in\/stories\/#website","url":"https:\/\/trak.in\/stories\/","name":"Trak.in - Indian Business of Tech, Mobile & Startups","description":"Trak.in is a popular Indian Business, Technology, Mobile & Startup blog featuring trending News, views and analytical take on Technology, Business, Finance, Telecom, Mobile, startups & Social Media Space","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/trak.in\/stories\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7","name":"Mohul Ghosh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g","caption":"Mohul Ghosh"},"url":"https:\/\/trak.in\/stories\/author\/mohul-ghosh\/"}]}},"jetpack_featured_media_url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2024\/05\/Untitled-design-14-1280x720-1-1024x576-1-1024x576-1-1.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1281480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/users\/30"}],"replies":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/comments?post=1281480"}],"version-history":[{"count":1,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1281480\/revisions"}],"predecessor-version":[{"id":1281482,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1281480\/revisions\/1281482"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/media\/1281481"}],"wp:attachment":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/media?parent=1281480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/categories?post=1281480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/tags?post=1281480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}